MHRA Safety Roundup

View as a webpage / Share

MHRA Safety Roundup

July 2026

This month's Safety Roundup includes:

Drug Safety Update on Botulinum toxin type A products: updated warnings regarding risk of iatrogenic botulism
Drug Safety Update on Domperidone: new contraindication in patients with phaeochromocytoma due to the risk of severe hypertension
Letters, medicines recalls and device notifications sent to healthcare professionals in July 2026 
News and guidance on:
- Immune checkpoint inhibitors: product information updated to include myocarditis-myositis-myasthenia gravis overlap syndrome
- Bladder anticholinergics: review of risk of dementia

July's Safety Roundup is now available to read as a downloadable document or on the GOV.UK website

It's easy to report

Report suspected adverse drug reactions and medical device incidents using the MHRA Yellow Card scheme.

REPORT ONLINE

Thank you,

The Medicines and Healthcare products Regulatory Agency

If you would like to share this with a friend or colleague, hit the Forward button or send them this link to view the email in a browser.

Unsubscribe or change your email address at any time on your subscriber preferences page.

If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com.

All other enquiries can be directed to email.support@mhra.gov.uk.

This is an automatically generated email. Please do not reply directly to this notification.
This service is provided to you at no charge by the Medicines and Healthcare products Regulatory Agency.